Niamh E. Buckley
97 Lisburn Road
Belfast, NIR, United Kingdom
Belfast, NIR, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Chemotherapeutics as Immune Modulators for the Treatment of Triple-Negative Breast Cancer.
Journal: Cancers
Published: April 22, 2026
A Five-Biomarker IHC-Based Signature Predicting Outcome in Breast Cancer Patients Following Adjuvant Anthracycline-Based Chemotherapy.
Journal: Cancers
Published: February 27, 2026
The Immunomodulatory Role of Gemcitabine in Triple Negative Breast Cancer.
Journal: Cells
Published: September 02, 2025
Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer.
Journal: Journal of ovarian research
Published: June 24, 2025
Development of a nano-vaccine for high-grade serous ovarian cancer.
Journal: Biomaterials science
Published: May 08, 2025
The search for a TNBC vaccine: the guardian vaccine.
Journal: Cancer biology & therapy
Published: March 16, 2025
Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors.
Journal: Expert review of molecular diagnostics
Published: February 20, 2025
Development and Characterization of a Peptide-Bisphosphonate Nanoparticle for the Treatment of Breast Cancer.
Journal: Molecular pharmaceutics
Published: August 28, 2024
Embryo movement is required for limb tendon maturation.
Journal: Frontiers in cell and developmental biology
Published: July 18, 2024
A SRC-slug-TGFβ2 signaling axis drives poor outcomes in triple-negative breast cancers.
Journal: Cell communication and signaling : CCS
Published: April 08, 2024
Structural determinants of tendon multiscale mechanics and their sensitivity to mechanical stimulation during development in an embryonic chick model.
Journal: Acta biomaterialia
Published: March 01, 2024
Synthesis and characterisation of a nucleotide based pro-drug formulated with a peptide into a nano-chemotherapy for colorectal cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 05, 2023
Last Updated: 09/26/2026